HOOK Valuation

HOOKIPA Pharma Inc

Add to Watchlist

Advanced Chart

0.000

-0.84(-99.964%)1D

Overview
Forecast
Valuation
Earnings

HOOK Relative Valuation

HOOK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOOK is overvalued; if below, it's undervalued.

Historical Valuation

HOOKIPA Pharma Inc (HOOK) is now in the Fair zone, suggesting that its current forward PS ratio of 1.25 is considered Fairly compared with the five-year average of -1.88. The fair price of HOOKIPA Pharma Inc (HOOK) is between 0.74 to 2.89 according to relative valuation methord.

Relative Value

Fair Zone

0.74-2.89

Current Price：0.83

Fair

-0.39

Trailing

Forward

0.00

EV/EBITDA

HOOKIPA Pharma Inc. (HOOK) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -1.91. The thresholds are as follows: Strongly Undervalued below -9.24, Undervalued between -9.24 and -5.57, Fairly Valued between 1.76 and -5.57, Overvalued between 1.76 and 5.42, and Strongly Overvalued above 5.42. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.28

EV/EBIT

HOOKIPA Pharma Inc. (HOOK) has a current EV/EBIT of 0.28. The 5-year average EV/EBIT is -1.58. The thresholds are as follows: Strongly Undervalued below -8.44, Undervalued between -8.44 and -5.01, Fairly Valued between 1.85 and -5.01, Overvalued between 1.85 and 5.28, and Strongly Overvalued above 5.28. The current Forward EV/EBIT of 0.28 falls within the Historic Trend Line -Fairly Valued range.

1.25

HOOKIPA Pharma Inc. (HOOK) has a current PS of 1.25. The 5-year average PS is 13.48. The thresholds are as follows: Strongly Undervalued below -18.47, Undervalued between -18.47 and -2.50, Fairly Valued between 29.45 and -2.50, Overvalued between 29.45 and 45.43, and Strongly Overvalued above 45.43. The current Forward PS of 1.25 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

HOOKIPA Pharma Inc. (HOOK) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.56. The thresholds are as follows: Strongly Undervalued below -12.91, Undervalued between -12.91 and -8.24, Fairly Valued between 1.11 and -8.24, Overvalued between 1.11 and 5.78, and Strongly Overvalued above 5.78. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

HOOKIPA Pharma Inc. (HOOK) has a current P/FCF of 0.00. The 5-year average P/FCF is -2.87. The thresholds are as follows: Strongly Undervalued below -10.46, Undervalued between -10.46 and -6.67, Fairly Valued between 0.92 and -6.67, Overvalued between 0.92 and 4.71, and Strongly Overvalued above 4.71. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

HOOKIPA Pharma Inc (HOOK) has a current Price-to-Book (P/B) ratio of 0.33. Compared to its 3-year average P/B ratio of 0.68 , the current P/B ratio is approximately -51.39% higher. Relative to its 5-year average P/B ratio of 1.89, the current P/B ratio is about -82.41% higher. HOOKIPA Pharma Inc (HOOK) has a Forward Free Cash Flow (FCF) yield of approximately -453.14%. Compared to its 3-year average FCF yield of -145.12%, the current FCF yield is approximately 212.25% lower. Relative to its 5-year average FCF yield of -95.89% , the current FCF yield is about 372.56% lower.

0.33

P/B

Median3y

0.68

Median5y

1.89

-453.14

FCF Yield

Median3y

-145.12

Median5y

-95.89

Competitors Valuation Multiple

The average P/S ratio for HOOK's competitors is 3.24, providing a benchmark for relative valuation. HOOKIPA Pharma Inc Corp (HOOK) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -94.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Phio Pharmaceuticals Corp

Performance Decomposition

Market capitalization of HOOK decreased by 80.46% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.01 to -0.15.

The secondary factor is the Revenue Growth, contributed -94.52%to the performance.

Overall, the performance of HOOK in the past 1 year is driven by P/E Change. Which is more unsustainable.

-94.52%

36.60M → 2.00M

Revenue Growth

-2058.80%

39.30 → -769.81

Margin Expansion

2072.86%

-0.01 → -0.15

P/E Change

-80.46%